secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2022-09-29T23:59:59+00:00
Accession:  0001493152-22-027158
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo raises $6.6M in private placement of common shares and warrants
-----------------------------------------------------------------------

- Sold 2,264,650 units at $2.935 each for aggregate proceeds of ~$6.6 million; each unit consists of one share and one warrant.
- Warrants exercisable at $4.215 per share, immediately exercisable, five-year term; beneficial ownership limitation applies.
- 22NW Fund, LP, an affiliate of director Aron English, purchased 1,703,577 units for ~$5.0 million.
- Net proceeds to advance development of ANEB-001 (acute cannabinoid intoxication) and for general corporate purposes.
- MTS Securities acted as placement agent; fee of 6% of gross proceeds (1% for 22NW participation) plus expenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000149315222027158/0001493152-22-027158-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000149315222027158/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-027158

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer